Buscar
Mostrando ítems 1-10 de 11
Pharmacological treatment compliance and a description of its associated factors in patients with myasthenia gravis
(Revista de Neurología, 2018)
Introduction. Medication adherence is a public health problem and this has not been previously studied in myasthenia gravis patients
Aim. To determine if patients with myasthenia gravis are adherent to treatment and ...
Dysfunctional chemosensation in myasthenia gravis : A systematic review
(2013-09)
Myasthenia gravis has traditionally been viewed as a disorder that solely affects the neuromuscular junction within the peripheral nervous system. However, there is now evidence that the cholinergic dysfunction of this ...
Clinical and epidemiological features of myasthenia gravis in Chilean population
(Blackwell Publishing Ltd, 2018)
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Objective: To provide an estimated prevalence and describe the clinical features of myasthenia gravis (MG) in Chile. Method: We carried out (i) a prevalence ...
Acute muscular weakness
(Assoc Arquivos Neuro- Psiquiatria, 2015)
Acute muscle weakness (AMW) is a pediatric emergency. During diagnostic approach, it is crucial
to obtain a detailed anamnesis, including: onset of weakness, history of associated febrile states,
ingestion of toxic ...
Miastenia gravis y su asociación con trastornos linfoproliferativos: casos clínicos
(Sociedad Médica Santiago, 2017)
Myasthenia gravis (MG) is a rare autoimmune disease of the neuromuscular
junction. It is characterized by variable weakness and excessive fatigability
of skeletal muscles. In the last few years, numerous reports have ...
Sensory aspects in myasthenia gravis : A translational approach
(2016-09-15)
Myasthenia gravis is a paradigmatic muscle disorder characterized by abnormal fatigue and muscle weakness that worsens with activities and improves with rest. Clinical and research studies done on nicotinic acetylcholine ...
Myotonic dystrophy in a female with myasthenia gravis
(2007)
The likelihood of coexistence in the same patient of myasthenia gravis and myotonic dystrophy has been estimated at I in 40 million. The case of a patient in whom both diagnoses were made is reported here. A 13-year-old ...
Pediatric ocular myasthenia gravis: Case report and literature review
(Pan-American Association of OphthalmologyEstados Unidos, 2019-12)
Objective: The objective was to describe a case of ocular myasthenia gravis (MG) in a pediatric patient.
Design: This is a descriptive, retrospective study and case report.
Methodology: For the purpose of the case report, ...
Minimal manifestation status and prednisone withdrawal in the MGTX trial
(Lippincott Williams & Wilkins, 2020)
To examine whether sustained minimal manifestation status (MMS) with complete withdrawal of prednisone is better achieved in thymectomized patients with myasthenia gravis (MG).
Methods
This study is a post hoc analysis ...